Accessibility statement

TEEHTA presentations

2011

2011 presentations

  • Cookson R.  Effects of NHS reform on socioeconomic equity in health care.  Guest Lecture, Wolfson Research Institute, December 2011.
  •  Despiégel N, Danchenko N, François C, Lensberg B, Drummond M. The use and performance of productivity scales to evaluate presenteeism in mood disorders. ISPOR 14th Annual European Congress, Madrid, 5-8 Nov 2011.
  • Soares MO, NJ Welton, P Peura, DA Harrison, M Shankar Hari, KM Rowan, SJ Palmer. The value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock). ISPOR, 14th annual European congress. Madrid (Nov 2011)
  • Drummond M. Twenty Years of Using Economic Evaluations for Drug Reimbursement Decisions. What Have We Achieved? 33rd Australian Conference of Health Economists, Melbourne, Sept 2011.
  • Cost-effectiveness thresholds for decision making about health care technologies: conceptual and empirical underpinnings
    Organised session, International Health Economics Association meeting, Toronto 13 july 2011.
  • Claxton K. After many a summer dies the swan (PDF , 402kb) Plenary debate: the value of innovation at the end of life. International Health Economics Association (iHEA), Toronto, July 2011. 
  • Claxton K. The cost-effectiveness threshold: (PDF , 441kb) what it is, what it’s not and how to estimate it? International Health Economics Association (iHEA),  Toronto, July 2011. 
  • Claxton K.Value based pricing for the NHS (PDF , 434kb) International Health Economics Association (iHEA), Toronto, July 2011. 
  • Claxton K. The complexity of the allocation problem in health care: (PDF , 427kb) can current decision rules provide a useful guide? International Health Economics Association (iHEA),  Toronto, July 2011.
  • Claxton K. Perspective and multi-sectoral effects. (PDF , 348kb) Symposium: Economic Evaluation Methods for Upstream Population Health Interventions. International Health Economics Association (iHEA), Toronto, July 2011. 
  • Drummond M. Economic Analysis in NICE Clinical Guidelines in the United Kingdom. International Health Economics Association (iHEA), Toronto, July 2011.
  • Cookson R.  Effects of choice and market reform on socioeconomic inequalities of access to health care, SDO Network CEO Forum, Nottingham, June 2011.
  • Cookson R. Effects of health reform on health care inequality. HSRN/SDO Annual Conference, Liverpool, June 2011.
  • Walker S. Value for money and the Quality and Outcomes Framework in primary care in the NHS- Health Sciences Group Primary Care Seminar, University of Manchester June 2011
  • Cookson R.  Happiness and capability approaches, NICE Annual Conference, 10-11 May 2011, Birmingham.
  • Drummond M. Restricting Access to Healthcare: Is NICE Too Nasty?  Presentation to the Public Health Economics Group, John Hopkins University, Baltimore, May 2011.
  • Soares MO, Bojke L, Dumville JC, Iglesias C, Cullum N, Claxton K. Using elicitation to quantify experts’ beliefs regarding the use of negative pressure wound therapy for severe pressure ulceration. The 2011 International Nursing Research Conference - Royal College of Nursing of the United Kingdom (Apr 2011).
  • Soares MO, McKenna C, Spackman E, Bojke L, Griffin S, Palmer S, Claxton K. Unifying research and reimbursement decisions: examining two case studies. Economic Evaluation and Health Technology Assessment Seminar Series (Feb 2011) 
  • Soares MO, Dumville JC, Iglesias C, Bojke L, Cullum N, Claxton K, Methods to assess cost effectiveness and value of further research when data are sparse: negative pressure wound therapy for severe pressure ulcers. Health Economists' Study Group meeting, York.  (Jan 2011)
  • Spackman E, Griffin S, Fleurence R, Kim E. "Model Busting": Methods and experience in the critical appraisal of cost-effectiveness models submitted to reimbursement agencies. ISPOR Madrid 2011.  Workshop.
  • Spackman E, Fleurence R, Kim E, Naci H.  Moving towards value based health care in different constituencies, A presentation on behalf of the ISPOR value based health care special interest group.  ISPOR Madrid 2011. Workshop.
  • Spackman E. The health economics of preventive medicine: Is an ounce of screening worth a pound (1.15 euro)?  EUFEP Krems Austria, 2011. Invited Talk.
  • Claxton K, Spackman E, Griffin S, Palmer S, Longworth L, Bojke L, Youn, J.  Unifying research and reimbursement decisions: a framework and algorithm for policy choice.  HESG 2011.
  • Longworth L, Youn J, Bojke L, Palmer S, Griffin S, Spackman E, Claxton K.  When does NICE issue ‘Approval with Evidence’ recommendations? A review of ‘Only In Research’ and ‘Approval With Research’ recommendations in NICE guidance. HESG 2011. 
  • Hinde S, Spackman E, Claxton K, Sculpher M. The cost-effectiveness threshold: The results of a novel literature review method.  ISPOR Madrid, Spain 2011. Poster.
  • Sullivan SD, Bloudek L, Spackman DE, Blankenburg M.  A Meta-analysis of Biomarkers and Diagnostic Imaging in Alzheimer's Disease.  ISPOR Baltimore, 2011.

2010

2010 presentations

2009

2009 presentations

2008

2008 presentations

2007

2007 presentations

2006

 

2006 presentations

  • Claxton K. Presentation at the NICE conference in Birmingham, Dangerous Omissions: The Consequences of Ignoring Decision Uncertainty (PDF , 259kb) Birmingham, December 2006.
  • Sculpher M.  Presentation Symposium on Funding & Reimbursement For Medical Devices, Brussels, December 2006. "Technology Appraisal of Medical Devices at NICE – Methods and Practice (PDF , 485kb) ".
  • Sculpher M.  Invited presentation at European Commission workshop on the Future challenges for ex-ante Economic Evaluations of New Health Technologies, Brussels, December 2006.  "The Importance of Decision Analytic Modelling (PDF , 170kb) in Evaluating Health Care Interventions".
  • Manca A. Invited presentation at European Commission workshop on the Future challenges for ex-ante Economic Evaluations of New Health Technologies, Brussels, December 2006. "Handling between-country differences in the analysis of patient-level multinational cost-effectiveness data".
  • Manca A. ISPOR Workshop on Transferability of Cost-Effectiveness Data Between Countries. "Transferability of the results of economic evaluation studies between countries: approaches to the problem". November 2006.
  • Bravo Vergel Y, Dunn G, Beynon S, N Woolacott, Soares-Weiser K, Geddes J, Gilbody S, Palmer S. A simultaneous comparison of multiple pharmacological treatments (PDF , 58kb) for bipolar I disorder: an application of Bayesian statistical methods. Cochrane Colloquium (October 23-26, 2006, Dublin).
  • Bojke L, Claxton K, Bravo Vergel Y. Using expert elicitation to resolve issues of structural uncertainty in decision analytic models. Annual Meeting of the Society for Medical Decision Making (October 14-18, 2006, Boston).
  • Sculpher M.  Invited talk at the 24th National Annual Meeting of the Spanish Society for Quality in Health Care, Toledo, Spain, October 2006.  The National Institute for Clinical Excellence in the UK – Experience and Impact (PDF , 436kb)
  • Sculpher M.  Invited lecture at the European Science Foundation-funded Conference on the Global Health Economy held near Kiel in Schleswig-Holstein, Germany, October 2006.  Decision Analysis as a Basis for Estimating Cost-Effectiveness (PDF , 248kb) : the Experience of NICE in the UK."
  • Sculpher M.  Invited lecture at the Dutch Health Care Insurance Board conference on Appraisal of the cost-effectiveness of expensive hospital drugs, Amsterdam, Netherlands, September 2006. Cost-Effectiveness Analysis in the UK. Lessons from NICE (PDF , 368kb)
  • Sculpher M, Drummond M.  Paper delivered at Better Analysis for Better Decisions, a conference to honour the work of Bernie O’Brien, McMaster University, July 2006. Matching analyses to decisions (PDF , 191kb) s: can we ever make economic evaluations generalisable across jurisdictions?"
  • Manca A, Willan A. Paper delivered at Better Analysis for Better Decisions, a conference to honour the work of Bernie O'Brien, McMaster University, Hamilton, Ontario, (Canada). July 2006 - "Lost in translation": accounting for between-country differences in the analysis of multinational cost-effectiveness data.
  • Bravo Vergel Y, Hawkins N, Asseburg C, Palmer S, Claxton K, Sculpher M. The Cost-Effectiveness and Value of Information Associated with Biologic Drugs for the Treatment of Psoriatic Arthritis. Presentation at TEEHTA, University of York, June 2006.
  • Sculpher M.  Issues Panel at the International Society of Pharmacoeconomics and Outcomes research, Philadelphia, USA, May 2006.  "Modelling heterogeneity in cost-effectiveness analysis (PDF , 335kb) : modelling variation for decision making."
  • Epstein D. Presented at the Society for Medical Decision Making European Meeting, Birmingham, UK.  12 June 2006. "Within trial cost effectiveness analysis with censored data (PDF , 94kb) ".

2003/2004/2005

2005 presentations

2004 presentations

2003 presentations